These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 10590913

  • 1. Use of leukotriene antagonists in childhood asthma.
    Krawiec ME, Wenzel SE.
    Curr Opin Pediatr; 1999 Dec; 11(6):540-7. PubMed ID: 10590913
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Asthma treatment: antileukotriene drugs.
    O'Byrne PM.
    Can Respir J; 1998 Dec; 5 Suppl A():64A-70A. PubMed ID: 9753521
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Antileukotrienes in the therapy of bronchial asthma].
    Riccioni G, Della Vecchia R, Menna V, Lambo MS, Di Ilio C, D'Orazio N.
    Recenti Prog Med; 2003 Nov; 94(11):509-15. PubMed ID: 14679921
    [Abstract] [Full Text] [Related]

  • 9. Antileukotriene agents in asthma: the dart that kills the elephant?
    Renzi PM.
    CMAJ; 1999 Jan 26; 160(2):217-23. PubMed ID: 9951445
    [Abstract] [Full Text] [Related]

  • 10. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment].
    Fal AM, Kopeć A.
    Pneumonol Alergol Pol; 2010 Jan 26; 78(1):68-73. PubMed ID: 20162521
    [Abstract] [Full Text] [Related]

  • 11. New treatments for asthma: the role of leukotriene modifier agents.
    Valacer DJ.
    J Natl Med Assoc; 1999 Aug 26; 91(8 Suppl):26S-39S. PubMed ID: 12653390
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood.
    Warner JO.
    Allergy; 2001 Aug 26; 56 Suppl 66():22-9. PubMed ID: 11421938
    [Abstract] [Full Text] [Related]

  • 15. Lipid mediator pathways in the lung: leukotrienes as a new target for the treatment of asthma.
    Dahlén SE.
    Clin Exp Allergy; 1998 Nov 26; 28 Suppl 5():141-6; discussion 171-3. PubMed ID: 9988460
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.
    Claesson HE, Dahlén SE.
    J Intern Med; 1999 Mar 26; 245(3):205-27. PubMed ID: 10205583
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Montelukast in childhood asthma: what is the evidence for its use?
    Amlani S, McIvor RA.
    Expert Rev Respir Med; 2011 Feb 26; 5(1):17-25. PubMed ID: 21348582
    [Abstract] [Full Text] [Related]

  • 20. Antileukotriene agents.
    Tan RA, Spector SL.
    Curr Opin Pulm Med; 1997 May 26; 3(3):215-20. PubMed ID: 9232368
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.